The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome

R Willis, EB Gonzalez, AR Brasier - Current Rheumatology Reports, 2015 - Springer
Pathogenic antiphospholipid antibodies (aPL) are the driving factors of recurrent pregnancy
loss and thrombosis that characterize antiphospholipid syndrome (APS). Current evidence …
被引用次数：37 相关文章

The Journey of Antiphospholipid Antibodies From Cellular Activation to Antiphospholipid Syndrome

R Willis, EB Gonzalez, AR Brasier - Current Rheumatology Reports, 2015 - infona.pl
Pathogenic antiphospholipid antibodies (aPL) are the driving factors of recurrent pregnancy
loss and thrombosis that characterize antiphospholipid syndrome (APS). Current evidence …

The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome

R Willis, EB Gonzalez… - Current rheumatology …, 2015 - pubmed.ncbi.nlm.nih.gov
Pathogenic antiphospholipid antibodies (aPL) are the driving factors of recurrent pregnancy
loss and thrombosis that characterize antiphospholipid syndrome (APS). Current evidence …

The Journey of Antiphospholipid Antibodies From Cellular Activation to Antiphospholipid Syndrome

R Willis, EB Gonzalez… - Current Rheumatology …, 2015 - researchexperts.utmb.edu
Pathogenic antiphospholipid antibodies (aPL) are the driving factors of recurrent pregnancy
loss and thrombosis that characterize antiphospholipid syndrome (APS). Current evidence …

The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.

R Willis, EB Gonzalez, AR Brasier - Current Rheumatology Reports, 2015 - europepmc.org
Pathogenic antiphospholipid antibodies (aPL) are the driving factors of recurrent pregnancy
loss and thrombosis that characterize antiphospholipid syndrome (APS). Current evidence …